| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 55.427 | 216.723 | 225.018 | 184.930 | 141.065 | 100.155 |
| Total Income - EUR | - | - | - | - | 55.511 | 216.917 | 225.917 | 185.820 | 145.698 | 108.765 |
| Total Expenses - EUR | - | - | - | - | 11.748 | 53.497 | 151.335 | 188.629 | 225.550 | 194.962 |
| Gross Profit/Loss - EUR | - | - | - | - | 43.762 | 163.420 | 74.582 | -2.809 | -79.852 | -86.197 |
| Net Profit/Loss - EUR | - | - | - | - | 42.098 | 156.916 | 67.831 | -8.359 | -81.309 | -88.750 |
| Employees | - | - | - | - | 0 | 1 | 0 | 0 | 2 | 2 |
Check the financial reports for the company - Medconsult Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 38.242 | 52.743 | 62.416 | 56.163 | 50.003 | 99.594 |
| Current Assets | - | - | - | - | 20.558 | 156.209 | 196.834 | 150.771 | 52.815 | 13.549 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 13.408 | 1.392 | 40 | 53.013 | 1.209 | 1.449 |
| Cash | - | - | - | - | 7.150 | 154.818 | 196.793 | 97.758 | 51.606 | 12.100 |
| Shareholders Funds | - | - | - | - | 42.140 | 198.258 | 214.127 | 163.743 | 81.937 | -7.271 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 16.660 | 10.694 | 45.122 | 43.192 | 20.881 | 120.415 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Medconsult Pharma S.r.l.